OXGENE, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics.
Our discovery technologies help pioneers advance their CAR-T, CRISPR, capsid or promoter discovery programmes. Our biomanufacturing solutions further accelerate the development and scalable manufacture of lentiviral, AAV or adenoviral vector based therapeutics.
Our pioneering spirit fuels us; we're open minded, collaborative, responsive and ambitious. We push the boundaries of possibility to drive breakthrough therapeutics from laboratory research all the way to clinical manufacture.